Small Molecules Overview

Principles

Definition

Small molecules is an academic concept and research domain primarily concerned with organic compounds characterized by relatively low molecular weight, typically differentiated from biological macromolecules such as proteins and nucleic acids. This field investigates their structure, properties, synthesis, and interactions, emphasizing their crucial roles as biological effectors, signaling molecules, and the basis for pharmaceutical development and chemical biology probes.

Ontological type

Drug Discovery Applications

Chemical Properties

Synthetic Strategies

Key developments

Key Figures

Diversity-Oriented Discovery era

K. Barry Sharpless [1] emerged as a leading figure in the Diversity-Oriented Discovery era, with affiliations at Massachusetts Institute of Technology [2] and Stanford University [3] during this period. In the 2001 paper Click Chemistry: Diverse Chemical Function from a Few Good Reactions [4], Sharpless articulated modular, reliable reactions that underpinned rapid library assembly, a hallmark of the era's diversity-driven, biology-guided screening. The era's emphasis on rapid, modular assembly and biology-guided screening drew directly on Sharpless [1]'s philosophy of reaction reliability and functional diversity. The collaboration between synthetic chemistry and chemical biology, as exemplified by Sharpless's work at MIT [2] and Stanford [3], helped establish workflows prioritizing structural diversity as the primary axis for hit-finding in this era.

Structure-Guided Optimization era

Arthur J. Olson [1], with affiliations spanning University of Naples Federico II [3] and University of Michigan [4], stands as a key figure in early structure-guided optimization for small molecules. Olson [1] authored the 2014 Small-Molecule Library Screening by Docking with PyRx [7], illustrating structure-guided docking-based library screening that accelerated candidate prioritization and translation of structural hypotheses into robust inhibitors. William L. Jorgensen [2], connected with Stanford University [5] and the University of Washington [6], is a central figure in advancing predictive force fields for structure-guided optimization. Jorgensen [2] authored the 2015 OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins [8], a transferable force field that extended predictive accuracy across diverse chemistries and reinforced structure-guided lead optimization.

Generative Targeted Design era

Representative authors in Generative Targeted Design for small molecules (2018–2024) include Jose G. Gómez-Bombarelli, Alán Aspuru-Guzik, Regina Barzilay, and the AlphaFold 2 team led by John Jumper. Gómez-Bombarelli pioneered neural encoder–decoder models that encode molecules into a continuous latent space for de novo design and multiobjective optimization. Aspuru-Guzik popularized inverse design and the integration of generative models with experimental constraints to enable design-first discovery. Barzilay advanced graph-based molecular generation and end-to-end AI workflows for predicting properties and guiding targeted design, while Jumper's AlphaFold 2 work strengthened structure-informed design of protein targets and covalent engagement strategies.